Recess, a maker of functional beverages and supplements centered on relaxation, will raise a Series B of at least $20 million later this year, CEO Ben Witte tells Axios exclusively.
Why it matters: The functional beverage category is expected to grow in value to almost $280 billion by 2030 from nearly $130 billion in 2021, according to Precedence Research.
